Refreshing results…
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial
UploadProgrammatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer
Download from doi.orgMissing publications? Search for publications with a matching author name.